Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

MFK Zaimer intends to conduct an IPO in early April

4/1/24 ZAYM

Nizhnekamskneftekhim reported for 2023 by IFRS

3/30/24 NKNC

Mechel reported for 2023 by RAS

3/29/24 MTLR

Lenta reported for 2023 by RAS

3/29/24 LENT

X5 Retail Group moves to Russia in a forced move

3/29/24 X5

Chelyabinsk Metallurgical Plant reported for 2023 by RAS

3/29/24 CHMK

Surgutneftegaz reported for 2023 by RAS

3/29/24 SNGS

Rusolovo reported for 2023 by RAS

3/29/24 ROLO

RSC Energia reported for 2023 by RAS

3/29/24 RKKE

NovaBev reported for 2023 by RAS

3/29/24 BELU